Use of metabolic imaging to monitor heterogeneity of tumour response following therapeutic mTORC1/2 pathway inhibition by Stephanie Ling, Alex Dexter, Alan M. Race, Shreya Sharma, Gregory Hamm, Urszula M. Polanska, Rosetta Consortium Cancer Research UK, John F. Marshall, Zoltan Takats, Kevin Brindle, Mariia O. Yuneva, George Poulogiannis, Andrew D. Campbell, Owen J. Sansom, Richard J. A. Goodwin, Josephine Bunch, Simon T. Barry

Get full text